Department of Statistics, Baylor University, Waco, TX, USA.
Comput Methods Programs Biomed. 2011 Nov;104(2):271-7. doi: 10.1016/j.cmpb.2010.10.010. Epub 2010 Dec 13.
Because of the high cost and time constraints for clinical trials, researchers often need to determine the smallest sample size that provides accurate inferences for a parameter of interest. Although most experimenters have employed frequentist sample-size determination methods, the Bayesian paradigm offers a wide variety of sample-size determination methodologies. Bayesian sample-size determination methods are becoming increasingly more popular in clinical trials because of their flexibility and easy interpretation inferences. Recently, Bayesian approaches have been used to determine the sample size of a single Poisson rate parameter in a clinical trial setting. In this paper, we extend these results to the comparison of two Poisson rates and develop methods for sample-size determination for hypothesis testing in a Bayesian context. We have created functions in R to determine the parameters for the conjugate gamma prior and calculate the sample size for the average length criterion and average power methods. We also provide two examples that implement our sample-size determination methods using clinical data.
由于临床试验的成本高、时间限制,研究人员通常需要确定提供感兴趣参数准确推断的最小样本量。尽管大多数实验者都采用了频率派样本量确定方法,但贝叶斯范式提供了各种各样的样本量确定方法。由于其灵活性和易于解释推断,贝叶斯样本量确定方法在临床试验中越来越受欢迎。最近,贝叶斯方法已被用于确定临床试验中单泊松率参数的样本量。本文将这些结果扩展到两个泊松率的比较,并为贝叶斯背景下的假设检验确定样本量的方法。我们在 R 中创建了一些函数,用于确定共轭伽马先验的参数,并计算平均长度准则和平均功效方法的样本量。我们还提供了两个示例,使用临床数据实现了我们的样本量确定方法。